Medicare AdvantageCoverageMedium impact
MA11.002n, Hematopoietic Stem Cell Transplantation
Independence Blue Cross·Oncology, Hematology·Medical Policy
Effective date
Apr 1, 2025
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA11.002n for Hematopoietic Stem Cell Transplantation has been updated with new requirements effective April 1, 2025. This affects billing and coverage for stem cell transplant procedures under Medicare Advantage plans.
Action Required
By April 1, 2025: Billing team must review the complete MA11.002n policy document at the source URL to identify specific changes to stem cell transplant billing requirements. Update billing procedures and prior authorization protocols for all hematopoietic stem cell transplantation services under Medicare Advantage plans. Verify current coverage criteria and documentation requirements have not changed.